HOTCHKIS & WILEY's ANIP Position Overview
HOTCHKIS & WILEY (via Hotchkis & Wiley Capital Management LLC) currently holds 204,017 shares of ANI Pharmaceuticals, Inc. (ANIP) worth $14.82 M, representing 0.04% of the portfolio. First purchased in 2024-Q3, this medium-term investment has been held for 9 quarters.
Based on 13F filings, HOTCHKIS & WILEY has maintained a strategic position in ANIP, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2026, adding 119,597 shares. Largest reduction occurred in Q2 2025, reducing 21,990 shares.
Analysis based on 13F filings available since 2013 Q2
HOTCHKIS & WILEY's ANI Pharmaceuticals (ANIP) Holding Value Over Time
Track share changes against reported price movement
Quarterly ANI Pharmaceuticals (ANIP) Trades by HOTCHKIS & WILEY
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2026 | +119,597 | Add 141.67% | 204,017 | $72.65 |
| Q2 2026 | +1,370 | Add 1.65% | 84,420 | $82.78 |
| Q1 2026 | +8,270 | Add 11.06% | 83,050 | $76.90 |
| Q4 2025 | +320 | Add 0.43% | 74,780 | $78.94 |
| Q3 2025 | -12,150 | Reduce 14.03% | 74,460 | $91.60 |
| Q2 2025 | -21,990 | Reduce 20.25% | 86,610 | $65.25 |
| Q1 2025 | +51,420 | Add 89.93% | 108,600 | $66.95 |
| Q4 2024 | +5,100 | Add 9.79% | 57,180 | $55.28 |
| Q3 2024 | +52,080 | New Buy | 52,080 | $59.66 |
HOTCHKIS & WILEY's ANI Pharmaceuticals Investment FAQs
HOTCHKIS & WILEY first purchased ANI Pharmaceuticals, Inc. (ANIP) in Q3 2024, acquiring 52,080 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
HOTCHKIS & WILEY has held ANI Pharmaceuticals, Inc. (ANIP) for 9 quarters since Q3 2024.
HOTCHKIS & WILEY's largest addition to ANI Pharmaceuticals, Inc. (ANIP) was in Q3 2026, adding 204,017 shares worth $14.82 M.
According to the latest 13F filing for Q3 2026, HOTCHKIS & WILEY's firm, Hotchkis & Wiley Capital Management LLC, owns 204,017 shares of ANI Pharmaceuticals, Inc. (ANIP), valued at approximately $14.82 M.
As of the Q3 2026 filing, ANI Pharmaceuticals, Inc. (ANIP) represents approximately 0.04% of HOTCHKIS & WILEY's publicly disclosed stock portfolio, making it one of their key holdings.
HOTCHKIS & WILEY's peak holding in ANI Pharmaceuticals, Inc. (ANIP) was 204,017 shares, as reported at the end of Q3 2026.